Aflatoxin M1 ELISA Kit (in Milk and Milk Products) |
|||
| DEIA2546 | Creative Diagnostics | 96T | EUR 939.6 |
|
Description: This kit is detection for Aflatoxin M1 in human serum or plase. |
|||
Biomarker Elisa Laboratories manufactures the biomarker in elisa reagents distributed by Genprice. The Biomarker In Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact biomarker elisa. Other Biomarker products are available in stock. Specificity: Biomarker Category: In Group: Elisa
Human True insulin ELISA kit |
||
| BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Human True insulin ELISA kit |
||
| BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Rat True insulin ELISA kit |
||
| BlueGene | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rat True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Rat True insulin ELISA kit |
||
| BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rat True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Rat True insulin ELISA kit |
||
| BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rat True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Goat True insulin ELISA kit |
||
| BlueGene | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Goat True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
Goat True insulin ELISA kit |
||
| BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Goat True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF568 conjugate, 0.1mg/mL |
|||
| BNC682760-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF568 conjugate, 0.1mg/mL |
|||
| BNC682760-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF594 conjugate, 0.1mg/mL |
|||
| BNC942759-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF594 conjugate, 0.1mg/mL |
|||
| BNC942759-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF594 conjugate, 0.1mg/mL |
|||
| BNC942760-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF594 conjugate, 0.1mg/mL |
|||
| BNC942760-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF640R conjugate, 0.1mg/mL |
|||
| BNC402759-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF640R conjugate, 0.1mg/mL |
|||
| BNC402759-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF640R conjugate, 0.1mg/mL |
|||
| BNC402760-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF640R conjugate, 0.1mg/mL |
|||
| BNC402760-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF488A conjugate, 0.1mg/mL |
|||
| BNC882759-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF488A conjugate, 0.1mg/mL |
|||
| BNC882759-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF488A conjugate, 0.1mg/mL |
|||
| BNC882760-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF488A conjugate, 0.1mg/mL |
|||
| BNC882760-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF405S conjugate, 0.1mg/mL |
|||
| BNC042759-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF405S conjugate, 0.1mg/mL |
|||
| BNC042759-500 | Biotium | 1uL | EUR 532 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF405S conjugate, 0.1mg/mL |
|||
| BNC042760-100 | Biotium | 1uL | EUR 192 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||